CA9 and neoplasm: The second set of evidence comes from experimental data showing that in a pancreatic tumor PDX model and an ovarian-adenocarcinoma-tumor-engrafted CAM model, S1P decreases hypoxia marker CA IX and enhances tumor oxygenation.